Douglas W Woods Selected Research

Tics (Tic)

4/2024	Perceived Negative Effects of Tic Management Strategies in Adults With Tic Disorders.
1/2022	Long-term Outcomes of Behavior Therapy for Youth With Tourette Disorder.
1/2021	Homework adherence predicts therapeutic improvement from behavior therapy in Tourette's disorder.
1/2020	Effect of behavior therapy for Tourette's disorder on psychiatric symptoms and functioning in adults.
1/2019	Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.
1/2019	Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.
1/2018	Self-esteem in adults with Tourette syndrome and chronic tic disorders: The roles of tic severity, treatment, and comorbidity.
1/2018	Neurocognitive correlates of treatment response in children with Tourette's Disorder.
3/2017	Moderators and predictors of response to behavior therapy for tics in Tourette syndrome.
1/2017	Comparing fixed-amount and progressive-amount DRO Schedules for tic suppression in youth with chronic tic disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas W Woods Research Topics

Disease

22	Tics (Tic) 04/2024 - 05/2010
14	Tic Disorders (Tic Disorder) 04/2024 - 05/2010
7	Tourette Syndrome (Tourette's Syndrome) 01/2016 - 08/2006
4	Trichotillomania 01/2023 - 09/2008
2	Movement Disorders (Movement Disorder) 01/2019 - 01/2016
2	Mental Disorders (Mental Disorder) 11/2018 - 01/2018
2	Excoriation Disorder 12/2015 - 08/2013
1	Weight Gain 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2016

Drug/Important Bio-Agent (IBA)

7	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2017 - 02/2013
1	tyramine-deoxysorbitolIBA 04/2024
1	P-2 (P 2)IBA 01/2020
1	Tiapride HydrochlorideIBA 01/2019
1	ziprasidone (Geodon)FDA Link 01/2019
1	ningdongIBA 01/2019
1	Aripiprazole (Abilify)FDA Link 01/2019
1	Topiramate (Topamax)FDA LinkGeneric 01/2019
1	Clonidine (ST 155)FDA LinkGeneric 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2019
1	Pimozide (Orap)FDA Link 01/2019
1	ProlactinIBA 01/2019
1	Dronabinol (THC)FDA LinkGeneric 01/2019
1	Guanfacine (Tenex)FDA LinkGeneric 01/2019
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2019
1	Type A Botulinum Toxins (Botox)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	A-factor (Streptomyces)IBA 01/2018
1	sperm releasing substanceIBA 12/2015
1	TarsIBA 01/2015
1	antineoplaston A10 (A 10)IBA 08/2013
1	Explosive Agents (Explosives)IBA 02/2012
1	Antipsychotic Agents (Antipsychotics)IBA 05/2010
1	trans-sodium crocetinate (crocetin)IBA 09/2008

Therapy/Procedure

17	Therapeutics 01/2023 - 05/2010
4	Deep Brain Stimulation 01/2019 - 04/2015
2	Aftercare (After-Treatment) 01/2021 - 12/2015
1	Injections 01/2019
1	Drug Therapy (Chemotherapy) 08/2006